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Background: Little is known about reasons that influence parents’ decision to participate in studies enrolling
healthy children. The aim of this observational study was to verify the reasons that lead pregnant women to give
their consent or to refuse participation to a newborn cohort study with a long follow up time.
Methods: To prospectively investigate the reasons that lead women to participate, to refuse the participation or to
withdraw from a newborn cohort study, three different questionnaires were administered to pregnant women
contacted or enrolled in the Phime cohort study, carried out in an Italian Hospital from 2007 to 2010.
Results: Phime study participation was refused by 304 women and 145 withdrew their consent during the follow
up. All these women filled in the related questionnaires. Within 632 mothers in follow up at 18 months, 430 filled in
the questionnaire on motivation to participate: 97% stated that the main reason was to contribute to research;
96% and 90% stated that they wanted to benefit future babies’ and mothers’ health. Ninety-six percent of women
would appreciate to know the results of analysis carried out on biological samples collected and of the overall
study results. One third of the mothers (37%) wanted to be involved in the definition of future similar studies,
bringing their experience and their views. Within the 304 women who refused participation, 56% stated that the
study was too demanding, 26% was not interested in participating and 18% was concerned about the need to
collect biological samples and to be submitted to neurocognitive tests. Fifty-two percent of 145 women who
withdrew after enrollment stated that the study was too demanding (52%), and 6% was concerned about the
biological samples collection.
Conclusions: The altruistic reason appears to be the main reported by women to decide to participate in a
newborn cohort study. The fact that the study was too demanding and the need to collect biological samples are
important reasons that lead women to refuse participation or to withdraw from the study. An adequate
communication on these aspects should minimize difficulties in enrolment and losses to follow up.
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Medical progress is closely linked to research. Clinical
studies such as randomized controlled trials or cohort
studies are crucial to increase knowledge about effective
interventions, risk and protective factors, prognosis of
diseases. The success of clinical studies depends on the
adequate enrollment of healthy or sick subjects, on their
compliance to the study protocol and on the* Correspondence: ronfani@burlo.trieste.it
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distribution, and reproduction in any mediumcompleteness of the follow up. The expectation of
people to receive adequate medical care often contrasts
with the lack of awareness of the importance to partici-
pate in clinical research. This is true particularly when
healthy people are asked to participate to studies or
when studies involve relative or family members [1]. In
the case of children participation to studies, parents are
almost always called to give consent. In this context, it is
crucial to understand what reasons influence parents’
decision. Available evidence on this topic are scanty.
Studies carried out in sick children show that the most
important reasons influencing parents’ decision areCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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reasons (i.e. to contribute to medical knowledge or to
help others) [2-4]. Other factors highlighted in the scien-
tific literature are the opportunity to have benefits (i.e.
financial benefits, free or new medications, gifts), the
duration of the study and where it is carried out, par-
ents’ attitude towards clinical trials and research, the
risk/benefit assessment and the socioeconomic status
[2,5-7].
The case in which researchers enroll healthy children
or parents of children before birth is more complex.
This happens, for example, in newborn cohort studies,
in which usually women were approached during preg-
nancy and the mother-child dyads are followed up for
years. This study design is particularly hard for parents
and their children, due to the long follow up, the need
to fill in very detailed questionnaires, the periodic child
evaluations in hospital or in outpatient setting, the
collection of biological samples. On this topic only
studies investigating the theoretical willingness of
mothers to participate to clinical research are available
[8,9]. Mothers were asked to imagine their children in-
volved in different studies’ scenarios with different level
of risk, discomfort and benefit. The results showed that
the willingness to consent is greater if the child is
healthy and the research is not intended to solve a
child’s specific problem. The degree of consent was
inversely proportional to the risk. The altruistic reason
was the main indicated by mothers to consent children
participation to high risk studies. To the best of our
knowledge, no field study assessing parents motivation
to accept or to refuse participation in newborns cohort
studies was carried out.
The aim of this observational study was to verify the
reasons that lead healthy pregnant women to give their
consent or to refuse participation to a newborn cohort
study with a long follow up time. The results would
contribute to improve the design and conduction of
observational clinical studies and the communication to
parents.
Methods
This survey was carried out at the Institute for Maternal
and Child Health IRCCS Burlo Garofolo of Trieste
(Italy), a third level hospital and one of the three
pediatric research institute recognized by the Italian
Ministry of Health.
The mothers of healthy term newborns contacted or
enrolled in the Phime cohort study (Public health impact
of long-term, low-level mixed element exposure in sus-
ceptible population strata, 6th Framework Program)
were asked to participate in this survey. The protocol of
the Phime study was approved February 5, 2007 by the
Bioethics Committee of the Institute for Maternal andchild Health IRCCS Burlo Garofolo. An amendment, in-
cluding a prolonged follow up (up to 7 years of child’s
life) and the possibility to re-contact parents in order to
carry out studies related with the Phime (such as the
present), was approved April 12, 2009. Subsequently,
women were contacted during the follow-up visits to
give their consent to fill-in the questionnaires about mo-
tivations. The informed consents for both the Phime and
the motivations studies were written and obtained face
to face by two trained researchers.
The Phime study assessed the association between
low-level prenatal mercury exposure through maternal
fish consumption and child neurodevelopment [10]. The
first results of the study are published elsewhere [11].
The participation to the Phime study was very demand-
ing for families. All the women living in the area of
Trieste, ≥18 years of age and Italian speaking were
contacted during pregnancy. After enrollment, at 20th-
22nd week of pregnancy (morphological ultrasound
screening), a blood sample was collected, a hair sample
was cut from the occipital area of the scalp and a brief
questionnaire about food habits, socio-demographic
information and health status was filled in; at 30th-32nd
week of pregnancy (biometric ultrasound screening) the
Raven’s standard progressive matrices test of intellectual
efficiency and general intelligence was administrated to
mothers and a urine sample was collected; at delivery a
cord blood sample, a piece of cord tissue and, when
possible, a sample of the first urine of the newborn were
collected; within the first month of life, a more extensive
questionnaire, including detailed food frequency ques-
tions and the evaluation of environmental exposures,
was filled in by mothers; a 24 hour breast milk collection
was carried out one month after birth; in the second year
of life, the child postnatal dietary exposure, including
types and amounts of food consumed, was recorded by
parents through a one week diary; at 18 months after
birth, a home visit was carried out to evaluate the famil-
iar environment using the HOME (Home Observation
for Measurement of the Environment) questionnaire;
finally, to evaluate the child neurocognitive abilities at
18 and at 40 months of life the Bayley Scales of Infant
and Toddler Development, Third edition (BSID III) was
administered during an ad hoc hospital visit.
The Phime study started the enrolment of women
during pregnancy in April 2007; the 18 months follow
up started in January 2009.
To evaluate the reasons that led women contacted for
the enrollment in the Phime cohort study to give or not
their consent to participate, two different questionnaires
were administered:
1) Women who give their consent: after the evaluation
of child neurocognitive abilities at 18 months of life
(BSID III), mothers were asked to fill in an anonymous
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of multiple choice questions investigating four areas: 1)
the reasons influencing the participation to the Phime
study; 2) the possible reasons affecting the choice to
participate to further studies or to refuse the participa-
tion; 3) the appropriateness of the enrollment place; 4)
the involvement during pregnancy in other studies other
than Phime. Socio demographic information (women
age, years of education, marital status, working situation)
were also collected. This questionnaire was not part of
the Phime study and was developed ad hoc. After receiv-
ing the approval of the Bioethical committee in April
2009, it was proposed to all mothers enrolled in the
Phime study and in follow up at 18 months. A
simplified version of the questionnaire is available as
Additional file 1.
2) Women who refused to participate or withdraw
their consent: these questionnaires were part of the
Phime study and they were administered to women at
the time of refusal or withdrawal. They include multiple
choice questions about the reasons which influenced the
refusal or the withdrawal and about socio demographic
characteristics.
The responses to the questionnaires were entered into
a database using EPIDATA (www.epidata.dk).
A descriptive analysis was carried out; categorical data
are presented as absolute frequencies and percentages;
continuous data as medians and interquartile ranges
(IQR). To compare the main socio-demographic vari-
ables available in questionnaires (women age at delivery
and level of education) among groups, the Kruskal-
Wallis test and the Fisher exact test were used respectively.
To evaluate the potential influence of socio-demographic
characteristics (women age, education, marital status, work-
ing situation) on the willingness to participate to further re-
search in women who filled in the questionnaire on
motivation to participate, a multiple logistic regression
analysis was carried out.
Results
One thousand five hundred ninety five women were
contacted during pregnancy; three hundred ninety-one
resulted not eligible (i.e., due to language barriers or hair
length insufficient for sample). Among the remaining
1204 women, 900 (75%) were enrolled and 304 refused
to participate. Seven hundred sixty-seven of the enrolled
women (85%) remained in the study at delivery and 632
children underwent BSID III testing at 18 months (70%
of the initial cohort). Overall, 268 of 900 women (30%)
left the study after enrollment: 50 became not eligible
(i.e., miscarriage, preterm birth, severe mother or child
intercurrent illness, etc.), 145 withdrew their consent to
continue the follow up and 73 were lost to follow up.
Four hundred and thirty mothers of the 632 childrenfollowed up at 18 months (68%) accepted to fill in the
questionnaire on motivation to participate.
The main characteristics of women which filled in the
questionnaires about motivation to participate (n = 430),
motivation to refuse (n = 304) and motivation to with-
draw (n = 145) are described in Table 1. Women who
withdrew participation presented a statistically signifi-
cant lower level of education.
Questionnaire on motivation for participation:
Table 2 describes the results concerning the reasons that
led mothers to participate to the Phime study. The most
frequent answer given by mothers was to contribute to re-
search and science (97%). Mothers interviewed had the cor-
rect perception that study participation would not have
been beneficial for them or for their babies but only for
future mothers and babies (90% and 96% respectively).
Almost all of the mothers (99%) stated that they felt
free to participate. Thirty-six percents stated that the
study participation was too time consuming, especially
with respect to filling in the alimentary diary.
Eighty-two percent of mothers answered that they would
participate to further research projects to contribute to re-
search and science (96%) (Table 3). The remaining 18%
stated that they would not participate mainly for the time
and the involvement required (92%) and for the need to
collect biological sample of the child (44%). At multivariate
analyses, socio demographic variables (age, marital status,
years of education, working situation) and being involved in
other studies did not influence the decision to participate
to further researches.
Eight percent of the interviewed women stated that the
time allowed to make a decision was too short and 6% that
the place where the enrollment took place was inadequate
(not comfortable, too small, without privacy).
Ninety-six percent of women would appreciate to
know the results of analysis carried out on biological
samples collected and of the overall study results. One
third of the mothers (37%) wanted to be involved in the
definition of future similar studies, bringing their experi-
ence and their views.
Questionnaire on motivation for refusal: at enroll-
ment, 304 pregnant women refused to participate to the
Phime project: 56% stated that the study was too de-
manding and that they had no time to participate, 26%
was not interested to participate and 18% was concerned
about the need to collect biological samples and to be
submitted to neurocognitive tests.
Questionnaire on motivation for withdrawal: this
questionnaire was filled in by 145 women who withdrew
after the enrollment (84 during pregnancy and 61 after
birth). The following reasons were stated to motivate the
withdrawal: study too demanding (52%), no more inter-
est in participating (14%), intercurrent health problems
for the women or for the child (12%), opposition to the
Table 1 Characteristics of women filling in the three questionnaires
Motivation to participate
questionnaire (n = 430)
Motivation to refuse
questionnaire (n = 304)
Motivation to withdraw
questionnaire (n = 145)
p value






62 (14.4) 46 (15.1) 37 (25.5) 0.008*
- High school /
University degree
368 (85.6) 258 (84.9) 108 (74.5)
* significant differences between first and third columns and between second and third columns (Fisher exact two tailed test, respectively p = 0.003
and p = 0.009).
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such as back to work, personal reasons, etc.
Discussion
Newborn cohorts are the most appropriate study design to
determine causation between risk or protective factors and
child health. Unfortunately, it is very expensive to conduct,
since it usually involves researchers and participants for
many years. Moreover, the long follow up puts the cohort
at risk of significant losses that lead to a reduction of in-
ternal and external study validity. In literature, little is
known about the real causes that lead to these losses. The
results of this observational study confirm the difficulties in
enrolment and the risk of loss to follow up related to new-
born cohort studies: only 900 of 1204 women eligible (75%)
decide to participate and, of these, only 70% were in follow
up 18 months after child birth. A relevant number of
women was lost to follow up or withdrew their consent
(24%). Women who withdrew the consent presented a
lower level of education while no differences were found
between women who refused and women still in follow up
at 18 months. This finding may be due to a higher propen-
sity in accepting to participate in the study without enough
conviction in women with lower educational level. There
were no differences in the age of the women enrolled in the
three groups. The main reasons reported by women to jus-
tify the non-participation or the withdrawal from the study
are common to these two groups: the newborn cohort
study is considered too demanding, requiring too much
time and a high level of involvement; women do not have
any interest in participating or this interest declines during
the follow up period; there is concern about possible risksTable 2 Reasons that lead women to participate to the
cohort study (n = 430)
To contribute to the research and science 97%
To consent that other children can take advantage from the
results of this study in the future
96%
To consent that other mothers can take advantage from the
results of this study in the future
90%
Study proposed by an institution in which I trust 78%associated with the collection, the long-term storage, the
future use of biological samples and with the need to ex-
pose a child seen as “healthy” to long and stressful
neurodevelopment tests. In addition to this data, it is im-
portant to highlight that almost 20% of women still in fol-
low up at 18 months stated that they were no longer
available to participate in further research projects. In this
population too, after child birth, concerns about collection
and long-term storage of biological samples became an im-
portant reason to refuse future participation in cohort
studies.
The altruistic reason appears to be the main reported
by women to decide to participate in the Phime study.
Almost all the enrolled women stated they would con-
tribute to research and science and to the health of other
mothers and children. This data confirms the results
shown by studies involving sick children [2-7].
The identification of the main causes that lead women to
participate to newborn cohort studies, to refuse the enrol-
ment or to withdraw the consent during follow up allow re-
searchers to develop strategies to minimize losses. To
achieve this goal, it is not possible to act by modifying the
study design or the follow up duration, which are
predetermined and linked to study objectives. However,
through the analysis of the answers provided by women in
the present study, some possible areas of work can be
identified:
– Given the importance of the altruistic reasons to
ensure women participation in newborn cohort
studies, the possible benefits for future mothers and
children would be emphasized in the informedTable 3 Reasons that lead women to participate to
further cohort studies or projects (n = 430)
To contribute to research and science 96%
To consent that other children can take advantage from the
results of these studies in the future
95%
To consent that other mothers can take advantage from the
results of these studies in the future
91%
Study is proposed by a institution in which I trust 74%
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researchers and women at enrolment.
– Correct and detailed information about the
collection, the long-term storage, the future use of
biological samples is also important. Literature on
this topic confirms the findings of the present paper.
Maternal attitudes toward DNA collection in
epidemiological studies was assessed through focus
groups [12,13]. Distrust of the government, fathers’
skepticism, and insufficient information about the
use, storage, and disposal of specimens were
reported as primary barriers to participation in DNA
collection. Addressing these concerns in study
materials might increase participation rates.
Altruism was reported as the primary reason for
participation. Noninvasive methods for DNA
collection or the use of residual samples were
preferred by most mothers. Parents concerns about
storage of residual newborn screening samples for
future use were also addressed in literature [14-16].
If the samples were stored and used for biomedical
research, stakeholders involved in focus groups
stated that an adequate informed consent would be
needed with some type of institutional review board
approval for protection [17]. The importance of
considering parental permission in storage of
residual newborn screening samples is confirmed by
a survey of a nationally representative sample of
USA parents: over three-quarters of parents
interviewed would be willing to permit the use of
their children’s samples for research purposes if
their permission was obtained prior to such use.
However, if permission was not obtained, more than
half of the parents would be ‘very unwilling’ to
permit use of their child’s sample [18].
These evidences from literature and the answers
given by mothers in the present study, address the
importance of an adequate and detailed information
to parents. Communication would occur during the
prenatal period [19] and would stress that
1) samples will be collected so as to cause the least
possible disturbance to the child (for example
during procedures already scheduled for clinical
reasons); 2) their storage will be adequate, following
pre-determined procedures and the national
legislation on bio-banking; details on how long the
samples will be stored and on what will happen to
the samples after the end of the study would be
provided; 3) the anonymity of the samples will be
provided through the use of appropriate coding;
4) the samples will be used exclusively for the
purpose of the study for which they were collected.
All this information would be included in the
informed consent form.– A percentage of women indicated as critical their
insufficient involvement both in the study design
phase and during the follow up period. Women
stated that the knowledge of results of tests carried
out and of the overall study results should be
appreciated and useful to motivate participation.
Literature on participatory research, that is the co-
construction of research between researchers and
people affected by the issues under study, provides
evidences that co-governance can be beneficial to
research contexts, processes and outcomes,
including increased recruitment and response rate
[20,21]. A more participatory approach in designing
cohort studies would allow researchers to work with
women and other stakeholders to select and justify
the strongest possible research methods, while
balancing research rigor with their responsiveness to
the community; emerging problems during the
enrolment phase and the follow up period could be
discussed and solved with the stakeholders. In our
setting, a more participatory approach in the Phime
study would have been possible, for example
involving groups of women who access the antenatal
classes carried out by primary care midwives. In the
Phime study, researchers tried to make the enrolled
women more involved in the study activities
through periodical letters with news and results.
This approach was not considered satisfactory by
some of the women enrolled. The creation of a
website and the periodical sending of SMS or e-
mails could strengthen the communication with
women after enrolment. A more active participation
could be obtained by using social networks, such as
Facebook or MySpace. This approach would allow
women to have a direct and real-time contact with
researchers and, even more important, with other
women enrolled. In literature, evidences of the use
of social networks for clinical purpose (i.e. patient-
physician relationship, health promotion programs)
and for research (i.e. public health research) were
found [22-25]. A recent paper addressing the role of
social networks in recruiting adolescent girls into a
follow up study, showed that loss to follow up was
minimized by contacting potential participants
through Facebook. In this study, researchers tried to
re-contact girls enrolled in a previous trial on
physical activity to re-recruit them in a follow up
study. Through Facebook, the researchers were able
to locate 9% and ultimately re-recruit 6% of the
participants of the previous study who they would
otherwise not have been able to reach using the
traditional recruitment methods [26]. The use of
social networks to fidelize women enrolled in
newborn cohort studies has never been explored.
Vecchi Brumatti et al. BMC Pediatrics 2013, 13:53 Page 6 of 7
http://www.biomedcentral.com/1471-2431/13/53Conclusions
This study, carried out in women contacted or enrolled
in a birth cohort study, made it possible to draw a
complete picture of motivation that lead women to
participate, to refuse the enrolment or to withdraw the
consent during follow up. This information allowed to
identify some possible areas to work on to try to
minimize difficulties in enrolment and to reduce the risk
of loss to follow up. A clear and adequate communication
(without hiding anything) with women during pregnancy,
addressing the possible benefits for future mothers and
children that may result from their participation in the
study and the management of some crucial steps of the
study (such as the collection, storage and use of biological
samples), is decisive both to convince women to partici-
pate and to remain in follow up. A more participatory
approach in designing the studies and a more active par-
ticipation of women during the follow up period should
contribute to reduce the losses. In this, a role of Internet
and in particular of social networks, such as Facebook, is
conceivable but it is still to be verified.Additional file
Additional file 1: A simplified version of the questionnaire on
motivation for participation.
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